MedTrace Logo

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

NCT02058927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 203

Last updated 2014-09-18

No results posted yet for this study

Summary

This is an observational study of HIV-1 infected children starting antiretroviral therapy to measure the magnitude and quality of general immune reconstitution and pathogen-specific immune reconstitution to measles virus.

Conditions

Interventions

DRUG

Measles vaccine

measles revaccination administered at 12 months from start of ART

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Carolyn B Moore, MD · University of North Carolina, Chapel Hill

Eligibility

Min Age
9 Months
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02058927 on ClinicalTrials.gov